换一批
换一批ERCC1, MLH1, MSH2, MSH6, and βIII-tubulin: resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma.
作者：
主题词
衔接蛋白质类, 信号转导(Adaptor Proteins, Signal Transducing);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);顺铂(Cisplatin);DNA结合蛋白质类(DNA-Binding Proteins);抗药性, 肿瘤(Drug Resistance, Neoplasm);内切核酸酶类(Endonucleases);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);免疫酶技术(Immunoenzyme Techniques);肺肿瘤(Lung Neoplasms);男(雄)性(Male);间皮瘤(Mesothelioma);中年人(Middle Aged);MutS同源蛋白2(MutS Homolog 2 Protein);肿瘤分期(Neoplasm Staging);核蛋白质类(Nuclear Proteins);预后(Prognosis);存活率(Survival Rate);组织阵列分析(Tissue Array Analysis);微管蛋白(Tubulin)
DOI
10.1016/j.cllc.2013.04.013
PMID
23810210
发布时间
2022-03-17
- 浏览50
Clinical lung cancer
558-567.e3页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
